Company: Alexion Pharmaceuticals
Job title: Vice President & Head, Research
Sharon Barr is the Vice President, Head of Research at Alexion Pharmaceuticals, responsible for drug discovery and early development as well as discovery and development of diagnostics, clinical biomarkers and bioanalytical sciences supporting the Alexion pipeline across various therapeutic areas including hematology, nephrology, neurology, metabolic disease and oncology. With 15 years industry experience in precision medicine, she has previously led the biomarkers team and a global development team at Alexion. Prior to this role she focused on the discovery and development of novel clinical biomarkers and companion diagnostics at Astellas Pharmaceuticals and OSI pharmaceuticals. Sharon received her PhD from New York University, and completed a postdoctoral fellowship at Stanford University.